C9orf72 and amyotrophic lateral sclerosis: In this context, TPN-101 has been investigated as a potential therapeutic agent for C9orf72-ALS, as it inhibits long interspersed nuclear element 1 reverse transcriptase activity to prevent immune responses and protect cells.